Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma

Study Title
Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma
Sponsor Name
NovoCure Ltd.
NCT Number
NCT03377491
IDE Number
G170288
CMS Approval Date
2018-04-04
Category
A

https://clinicaltrials.gov/ct2/show/NCT03377491?term=NCT03377491&rank=1